Mark De Rosch - May 1, 2025 Form 3 Insider Report for CervoMed Inc. (CRVO)

Role
EVP, RA and GA and PgM
Signature
/s/ William R. Elder, Attorney-in-Fact for Mark De Rosch
Stock symbol
CRVO
Transactions as of
May 1, 2025
Transactions value $
$0
Form type
3
Date filed
5/23/2025, 04:12 PM
Previous filing
Jan 23, 2023
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
De Rosch Mark EVP, RA and GA and PgM C/O CERVOMED INC., 20 PARK PLAZA, SUITE 424, BOSTON /s/ William R. Elder, Attorney-in-Fact for Mark De Rosch 2025-05-23 0001890320

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRVO Stock Option (Right to Buy) May 1, 2025 Common Stock 32K $12.53 Direct F1
holding CRVO Stock Option (Right to Buy) May 1, 2025 Common Stock 27K $2.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares granted as an inducement award material to Dr. De Rosch's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Award vests in equal monthly installments over thirty-six (36) months on the last day of each month commencing November 30, 2024.
F2 Shares granted under the Issuer's 2015 Equity Incentive Plan, as amended. Award vests in equal monthly installments over thirty-six (36) months on the last day of each month commencing February 28, 2025.

Remarks:

Exhibit 24.1 – Power of Attorney